BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 29958714)

  • 21. Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients.
    Verdecchia P; Angeli F; Pittavini L; Gattobigio R; Benemio G; Porcellati C
    Ital Heart J; 2004 Jul; 5(7):505-10. PubMed ID: 15487267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation.
    De With RR; Marcos EG; Van Gelder IC; Rienstra M
    Europace; 2018 Nov; 20(11):1750-1757. PubMed ID: 29518195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J-RHYTHM II Study).
    Suzuki T; Yamazaki T; Ogawa S; Nagai R; Yamashita T;
    Heart Rhythm; 2011 Dec; 8(12):1831-6. PubMed ID: 21816128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achieving a Systolic Blood Pressure Below 130 mmHg Reduces the Incidence of Cardiovascular Events in Hypertensive Patients with Echocardiographic Left Ventricular Hypertrophy.
    Lembo M; Trimarco V; Izzo R; Manzi MV; Rozza F; Gallo P; Morisco C; Bardi L; Esposito G; Forzano I; Santulli G; Trimarco B
    J Pharmacol Exp Ther; 2024 Jun; 390(1):4-10. PubMed ID: 38135511
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between left atrial tissue structural remodelling detected using late gadolinium enhancement MRI and left ventricular hypertrophy in patients with atrial fibrillation.
    Akkaya M; Higuchi K; Koopmann M; Burgon N; Erdogan E; Damal K; Kholmovski E; McGann C; Marrouche NF
    Europace; 2013 Dec; 15(12):1725-32. PubMed ID: 23711578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QTc dispersion and Cornell duration product can predict 10-year outcomes in hypertensive patients with left ventricular hypertrophy.
    Djordjević DB; Tasić IS; Kostić SI; Stamenković BN; Djordjević AD; Lović DB
    Clin Cardiol; 2017 Dec; 40(12):1236-1241. PubMed ID: 29247525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular hypertrophy phenotype to predict incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.
    Wang L; Yi J; Zhou Z; Liu J; Li Y; Tian A; Ren X; Zheng X
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1399-1406. PubMed ID: 38402001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upstream therapeutic strategies of valsartan and fluvastatin on hypertensive patients with non-permanent atrial fibrillation.
    Zhao Z; Niu X; Dong Z; Qi W; Liu E; Liu T; Li L; Liang Y; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12478. PubMed ID: 30390409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network).
    Gerdts E; Izzo R; Mancusi C; Losi MA; Manzi MV; Canciello G; De Luca N; Trimarco B; de Simone G
    Int J Cardiol; 2018 May; 258():257-261. PubMed ID: 29544940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial differences in incident atrial fibrillation among hypertensive patients during antihypertensive therapy.
    Okin PM; Bang CN; Wachtell K; Hille DA; Kjeldsen SE; Julius S; Dahlöf B; Devereux RB
    Am J Hypertens; 2014 Jul; 27(7):966-72. PubMed ID: 24552888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population.
    Cuspidi C; Facchetti R; Bombelli M; Tadic M; Sala C; Grassi G; Mancia G
    Hypertension; 2019 Mar; 73(3):612-619. PubMed ID: 30612493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.
    Pierdomenico SD; Lapenna D; Cuccurullo F
    Am J Hypertens; 2008 Apr; 21(4):464-70. PubMed ID: 18369364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort.
    Weijs B; Pisters R; Nieuwlaat R; Breithardt G; Le Heuzey JY; Vardas PE; Limantoro I; Schotten U; Lip GY; Crijns HJ
    Europace; 2012 Feb; 14(2):184-90. PubMed ID: 22135317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM; Wachtell K; Gerdts E; Dahlöf B; Devereux RB
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Left Ventricular Hypertrophy and Atrial Fibrillation with Hemorrhagic Evolution of Small Vessel Disease.
    Muscari A; Masetti G; Faccioli L; Ghinelli M; Pastore Trossello M; Puddu GM; Spinardi L; Zoli M
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105946. PubMed ID: 34214964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
    Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
    Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese.
    Wang SX; Xue H; Zou YB; Sun K; Fu CY; Wang H; Hui RT
    Chin Med J (Engl); 2012 Jan; 125(1):21-6. PubMed ID: 22340460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of left ventricular hypertrophy, atrial fibrillation and cardiovascular disease in hypertensive patients of Andalusia, Spain. PREHVIA study].
    Martín-Rioboó E; García Criado E; Pérula De Torres LA; Cea-Calvo L; Anguita Sánchez M; López Granados A; Ureña Fernández T; García Matarín L; Molina Díaz R;
    Med Clin (Barc); 2009 Feb; 132(7):243-50. PubMed ID: 19248873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of hypertension with or without diabetes on left ventricular remodeling in rural Chinese population: a cross-sectional study.
    Li T; Chen S; Guo X; Yang J; Sun Y
    BMC Cardiovasc Disord; 2017 Jul; 17(1):206. PubMed ID: 28750662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.